About the book
COVID-19 is a rampant worldwide problem. It is caused by the SARS-CoV-2 virus and has manifested into different variants. Previously, the delta variant has compromised existing therapeutic and preventive options for this disease. Now, the omicron variant is beginning to replace the others. In this respect, strategies to treat and cure COVID-19 should be devised. In the light of pharmaceutical biotechnology, three different approaches could be catered to resolve this issue. First, Computer-Aided Drug Design (CADD) approach. Second, rational drug design in the wet lab approach. Third, is the advanced drug delivery system. These approaches are influenced heavily by advances in life sciences such as the inception of structural bioinformatics as an independent study, the establishment of nanobiotechnology as a standard approach in drug design, and high advancement in structural biology such as the development of the CryoEM method. This book will focus on providing possible solutions toward this ongoing COVID-19 pandemic, in the light of those advancements in life sciences.